NOVEOME Trademark

Trademark Overview

On Friday, December 18, 2015, a trademark application was filed for NOVEOME with the United States Patent and Trademark Office. The USPTO has given the NOVEOME trademark a serial number of 86853847. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, November 3, 2023. This trademark is owned by Stemnion, Inc.. The NOVEOME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations consisting primarily of amniotic cells for modulating immune system function, modulating tissue rejection, and repairing damaged tissues; Pharmaceutical preparations consisting primarily of cell growth medium conditioned by amniotic cells for modulating inflammation, repairing damaged tissues, and restoring tissue homeostasis; house mark for pharmaceutical preparations for modulating immune system function, modulating tissue rejection, repairing damaged tissues, modulating inflammation, and restoring tissue homeostasis
noveome

General Information

Serial Number86853847
Word MarkNOVEOME
Filing DateFriday, December 18, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, November 3, 2023
Registration Number5219355
Registration DateTuesday, June 6, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations consisting primarily of amniotic cells for modulating immune system function, modulating tissue rejection, and repairing damaged tissues; Pharmaceutical preparations consisting primarily of cell growth medium conditioned by amniotic cells for modulating inflammation, repairing damaged tissues, and restoring tissue homeostasis; house mark for pharmaceutical preparations for modulating immune system function, modulating tissue rejection, repairing damaged tissues, modulating inflammation, and restoring tissue homeostasis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 29, 2015
Primary Code005
First Use Anywhere DateMonday, November 14, 2016
First Use In Commerce DateMonday, November 14, 2016

Trademark Owner History

Party NameNOVEOME BIOTHERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219
Party NameNOVEOME BIOTHERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPITTSBURGH, PA 15219
Party NameNOVEOME BIOTHERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressPITTSBURGH, PA 15219
Party NameStemnion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15219

Trademark Events

Event DateEvent Description
Friday, November 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 8, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, June 6, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 8, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 8, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 6, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, May 3, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 2, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 6, 2017ASSIGNED TO LIE
Thursday, March 23, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 18, 2017NON-FINAL ACTION E-MAILED
Saturday, February 18, 2017SU - NON-FINAL ACTION - WRITTEN
Tuesday, February 7, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 17, 2017USE AMENDMENT FILED
Friday, February 3, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 17, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, December 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 8, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 7, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 7, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 8, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 8, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 13, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, April 13, 2016PRIORITY ACTION E-MAILED
Wednesday, April 13, 2016PRIORITY ACTION WRITTEN
Wednesday, April 6, 2016ASSIGNED TO EXAMINER
Wednesday, March 16, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 29, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 22, 2015NEW APPLICATION ENTERED

Related Keywords

noveome modulating tissue tissues repairing preparations pharmaceutical damaged inflammation homeostasis restoring